BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26068761)

  • 1. Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness.
    Caceres G; Puskas JA; Magliocco AM
    Cancer Control; 2015 Apr; 22(2):167-76. PubMed ID: 26068761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Circulating Tumor Cells Using Microfluidics.
    Burinaru TA; Avram M; Avram A; Mărculescu C; Ţîncu B; Ţucureanu V; Matei A; Militaru M
    ACS Comb Sci; 2018 Mar; 20(3):107-126. PubMed ID: 29363937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic technologies for circulating tumor cell isolation.
    Cho H; Kim J; Song H; Sohn KY; Jeon M; Han KH
    Analyst; 2018 Jun; 143(13):2936-2970. PubMed ID: 29796523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
    De Souza LM; Robertson BM; Robertson GP
    Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells.
    Gazzaniga P; Raimondi C; Nicolazzo C; Carletti R; di Gioia C; Gradilone A; Cortesi E
    Expert Rev Mol Diagn; 2015; 15(7):925-32. PubMed ID: 25959553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
    Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW
    PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
    Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
    Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.
    Mohamadi RM; Besant JD; Mepham A; Green B; Mahmoudian L; Gibbs T; Ivanov I; Malvea A; Stojcic J; Allan AL; Lowes LE; Sargent EH; Nam RK; Kelley SO
    Angew Chem Int Ed Engl; 2015 Jan; 54(1):139-43. PubMed ID: 25377874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
    Romano G
    Drugs Today (Barc); 2017 Sep; 53(9):501-514. PubMed ID: 29238763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
    Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
    PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.